|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics. 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics. 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
3
|
Liotta LA and Kohn EC: The
microenvironment of the tumour-host interface. Nature. 411:375–379.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tanner GA: Kidney functionMedical
Physiology: Principles for Clinical Medicine. Rhoades RA and Bell
DR: 3rd. Lippincott Williams & Wilkins; Philadelphia: pp.
4202009
|
|
5
|
Alitalo K, Tammela T and Petrova TV:
Lymphangiogenesis in development and human disease. Nature.
438:946–953. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rossi A, Weber E, Sacchi G, Maestrini D,
Di Cintio F and Gerli R: Mechanotransduction in lymphatic
endothelial cells. Lymphology. 40:102–113. 2007.PubMed/NCBI
|
|
7
|
Scavelli C, Weber E, Aglianò M, Cirulli T,
Nico B, Vacca A and Ribatti D: Lymphatics at the crossroads of
angiogenesis and lymphangiogenesis. J Anat. 204:433–449. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Young B, Lowe JS, Stevens A, Heath JW and
Deakin PJ: Immune systemsWheater's Functional Histology: A Text and
Colour Atlas. 5th. Churchill Livingstone; New York, NY: pp.
219–220. 2006
|
|
9
|
von Andrian UH and Mempel TR: Homing and
cellular traffic in lymph nodes. Nat Rev Immunol. 3:867–878. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fischer M, Franzeck UK, Herrig I, Costanzo
U, Wen S, Schiesser M, Hoffmann U and Bollinger A: Flow velocity of
single lymphatic capillaries in human skin. Am J Physiol.
270:H358–H363. 1996.PubMed/NCBI
|
|
11
|
Mohammed RA, Martin SG, Gill MS, Green AR,
Paish EC and Ellis IO: Improved methods of detection of
lymphovascular invasion demonstrate that it is the predominant
method of vascular invasion in breast cancer and has important
clinical consequences. Am J Surg Pathol. 31:1825–1833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Coleman RE and Rubens RD: The clinical
course of bone metastases from breast cancer. Br J Cancer.
55:61–66. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Selzner M, Morse MA, Vredenburgh JJ,
Meyers WC and Clavien PA: Liver metastases from breast cancer:
Long-term survival after curative resection. Surgery. 127:383–389.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu
W, Giri DD, Viale A, Olshen AB, Gerald WL and Massagué J: Genes
that mediate breast cancer metastasis to lung. Nature. 436:518–524.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin NU, Bellon JR and Winer EP: CNS
metastases in breast cancer. J Clin Oncol. 22:3608–3617. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hartveit E: Attenuated cells in breast
stroma: The missing lymphatic system of the breast. Histopathology.
16:533–543. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fernandis AZ, Prasad A, Band H, Klösel R
and Ganju RK: Regulation of CXCR4-mediated chemotaxis and
chemoinvasion of breast cancer cells. Oncogene. 23:157–167. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Psaila B and Lyden D: The metastatic
niche: Adapting the foreign soil. Nat Rev Cancer. 9:285–293. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Klein CA: The systemic progression of
human cancer: A focus on the individual disseminated cancer cell -
the unit of selection. Adv Cancer Res. 89:35–67. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Paget S: The distribution of secondary
growths in cancer of the breast. Lancet. 133:571–573. 1889.
View Article : Google Scholar
|
|
22
|
Demicheli R: Tumour dormancy: Findings and
hypotheses from clinical research on breast cancer. Semin Cancer
Biol. 11:297–306. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu S, Dontu G, Mantle ID, Patel S, Ahn
NS, Jackson KW, Suri P and Wicha MS: Hedgehog signaling and Bmi-1
regulate self-renewal of normal and malignant human mammary stem
cells. Cancer Res. 66:6063–6071. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ranganathan AC, Adam AP, Zhang L and
Aguirre-Ghiso JA: Tumor cell dormancy induced by p38SAPK and
ER-stress signaling: An adaptive advantage for metastatic cells?
Cancer Biol Ther. 5:729–735. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Noh H, Hong S and Huang S: Role of
urokinase receptor in tumor progression and development.
Theranostics. 3:487–495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jones T, Neboori H, Wu H, Yang Q, Haffty
BG, Evans S, Higgins S and Moran MS: Are breast cancer subtypes
prognostic for nodal involvement and associated with
clinicopathologic features at presentation in early-stage breast
cancer? Ann Surg Oncol. 20:2866–2872. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Watnick RS, Cheng YN, Rangarajan A, Ince
TA and Weinberg RA: Ras modulates Myc activity to repress
thrombospondin-1 expression and increase tumor angiogenesis. Cancer
Cell. 3:219–231. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Perou CM, Sørlie T, Eisen MB, et al:
Molecular portraits of human breast tumours. Nature. 406:747–752.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rakha EA, El-Rehim DA, Paish C, Green AR,
Lee AH, Robertson JF, Blamey RW, Macmillan D and Ellis IO: Basal
phenotype identifies a poor prognostic subgroup of breast cancer of
clinical importance. Eur J Cancer. 42:3149–3156. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kennecke H, Yerushalmi R, Woods R, Cheang
MC, Voduc D, Speers CH, Nielsen TO and Gelmon K: Metastatic
behavior of breast cancer subtypes. J Clin Oncol. 28:3271–3277.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Howland NK, Driver TD, Sedrak MP, Wen X,
Dong W, Hatch S, Eltorky MA and Chao C: Lymph node involvement in
immunohistochemistry-based molecular classifications of breast
cancer. J Surg Res. 185:697–703. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Smid M, Wang Y, Klijn JG, Sieuwerts AM,
Zhang Y, Atkins D, Martens JW and Foekens JA: Genes associated with
breast cancer metastatic to bone. J Clin Oncol. 24:2261–2267. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Colleoni M, Rotmensz N, Maisonneuve P, et
al: Prognostic role of the extent of peritumoral vascular invasion
in operable breast cancer. Ann Oncol. 18:1632–1640. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hirakawa S, Brown LF, Kodama S, Paavonen
K, Alitalo K and Detmar M: VEGF-C-induced lymphangiogenesis in
sentinel lymph nodes promotes tumor metastasis to distant sites.
Blood. 109:1010–1017. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mattila MM, Ruohola JK, Karpanen T,
Jackson DG, Alitalo K and Härkönen PL: VEGF-C induced
lymphangiogenesis is associated with lymph node metastasis in
orthotopic MCF-7 tumors. Int J Cancer. 98:946–951. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Caine GJ, Stonelake PS, Lip GY and Blann
AD: Changes in plasma vascular endothelial growth factor,
angiopoietins, and their receptors following surgery for breast
cancer. Cancer Lett. 248:131–136. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Oliver G and Detmar M: The rediscovery of
the lymphatic system: Old and new insights into the development and
biological function of the lymphatic vasculature. Genes Dev.
16:773–783. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nakamura Y, Yasuoka H, Tsujimoto M, Yang
Q, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I and Kakudo K:
Flt-4-positive vessel density correlates with vascular endothelial
growth factor-d expression, nodal status, and prognosis in breast
cancer. Clin Cancer Res. 9:5313–5317. 2003.PubMed/NCBI
|
|
40
|
Nakamura Y, Yasuoka H, Tsujimoto M, Imabun
S, Nakahara M, Nakao K, Nakamura M, Mori I and Kakudo K: Lymph
vessel density correlates with nodal status, VEGF-C expression, and
prognosis in breast cancer. Breast Cancer Res Treat. 91:125–132.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nakamura Y, Yasuoka H, Tsujimoto M, Yang
Q, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I and Kakudo K:
Prognostic significance of vascular endothelial growth factor D in
breast carcinoma with long-term follow-up. Clin Cancer Res.
9:716–721. 2003.PubMed/NCBI
|
|
42
|
Mandriota SJ, Jussila L, Jeltsch M, et al:
Vascular endothelial growth factor-C-mediated lymphangiogenesis
promotes tumour metastasis. EMBO J. 20:672–682. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Van Trappen PO and Pepper MS:
Lymphangiogenesis and lymph node microdissemination. Gynecol Oncol.
82:1–3. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Witte MH, Way DL, Witte CL and Bernas M:
Lymphangiogenesis: Mechanisms, significance and clinical
implications. EXS. 79:65–112. 1997.PubMed/NCBI
|
|
45
|
Wigle JT, Harvey N, Detmar M, et al: An
essential role for Prox1 in the induction of the lymphatic
endothelial cell phenotype. EMBO J. 21:1505–1513. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Watanabe O, Kinoshita J, Shimizu T,
Imamura H, Hirano A, Okabe T, Aiba M and Ogawa K: Expression of a
CD44 variant and VEGF-C and the implications for lymphatic
metastasis and long-term prognosis of human breast cancer. J Exp
Clin Cancer Res. 24:75–82. 2005.PubMed/NCBI
|
|
47
|
Currie MJ, Hanrahan V, Gunningham SP,
Morrin HR, Frampton C, Han C, Robinson BA and Fox SB: Expression of
vascular endothelial growth factor D is associated with hypoxia
inducible factor (HIF-1alpha) and the HIF-1alpha target gene DEC1,
but not lymph node metastasis in primary human breast carcinomas. J
Clin Pathol. 57:829–834. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Carter CL, Allen C and Henson DE: Relation
of tumor size, lymph node status, and survival in 24,740 breast
cancer cases. Cancer. 63:181–187. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ioachim HL and Medeiros LJ: Metastatic
breast carcinomaIoachim's Lymph Node Pathology. 4th. Lippincott
Williams & Wilkins; Philadelphia: pp. 6062009
|
|
50
|
Woodward WA, Strom EA, Tucker SL, et al:
Changes in the 2003 American Joint Committee on Cancer staging for
breast cancer dramatically affect stage-specific survival. J Clin
Oncol. 21:3244–3248. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fisher B, Jeong JH, Anderson S, Bryant J,
Fisher ER and Wolmark N: Twenty-five-year follow-up of a randomized
trial comparing radical mastectomy, total mastectomy, and total
mastectomy followed by irradiation. N Engl J Med. 347:567–575.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Veronesi U, Viale G, Paganelli G, et al:
Sentinel lymph node biopsy in breast cancer: Ten-year results of a
randomized controlled study. Ann Surg. 251:595–600. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Warmuth MA, Bowen G, Prosnitz LR, Chu L,
Broadwater G, Peterson B, Leight G and Winer EP: Complications of
axillary lymph node dissection for carcinoma of the breast: A
report based on a patient survey. Cancer. 83:1362–1368. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Petrek JA and Heelan MC: Incidence of
breast carcinoma-related lymphedema. Cancer. 83:2776–2781. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Goldhirsch A, Glick JH, Gelber RD and Senn
HJ: Meeting highlights: International Consensus Panel on the
Treatment of Primary Breast Cancer. J Natl Cancer Inst.
90:1601–1608. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Robinson DS, Senofsky GM and Ketcham AS:
Role and extent of lymphadenectomy for early breast cancer. Semin
Surg Oncol. 8:78–82. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Fleissig A, Fallowfield LJ, Langridge CI,
et al: Post-operative arm morbidity and quality of life. Results of
the ALMANAC randomised trial comparing sentinel node biopsy with
standard axillary treatment in the management of patients with
early breast cancer. Breast Cancer Res Treat. 95:279–293. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Krag DN, Anderson SJ, Julian TB, et al:
Sentinel-lymph-node resection compared with conventional
axillary-lymph-node dissection in clinically node-negative patients
with breast cancer: Overall survival findings from the NSABP B-32
randomised phase 3 trial. Lancet Oncol. 11:927–933. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Lyman GH, Giuliano AE, Somerfield MR, et
al: American Society of Clinical Oncology: American Society of
Clinical Oncology guideline recommendations for sentinel lymph node
biopsy in early-stage breast cancer. J Clin Oncol. 23:7703–7720.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Strauss LG and Conti PS: The applications
of PET in clinical oncology. J Nucl Med. 32:623–648.
1991.PubMed/NCBI
|
|
61
|
Eubank WB, Mankoff DA, Schmiedl UP, Winter
TC III, Fisher ER, Olshen AB, Graham MM and Eary JF: Imaging of
oncologic patients: Benefit of combined CT and FDG PET in the
diagnosis of malignancy. AJR Am J Roentgenol. 171:1103–1110. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Cooper KL, Meng Y, Harnan S, Ward SE,
Fitzgerald P, Papaioannou D, Wyld L, Ingram C, Wilkinson ID and
Lorenz E: Positron emission tomography (PET) and magnetic resonance
imaging (MRI) for the assessment of axillary lymph node metastases
in early breast cancer: Systematic review and economic evaluation.
Health Technol Assess. 15(iii-iv): 1–134. 2011.
|
|
63
|
McElroy M, Hayashi K, Garmy-Susini B,
Kaushal S, Varner JA, Moossa AR, Hoffman RM and Bouvet M:
Fluorescent LYVE-1 antibody to image dynamically lymphatic
trafficking of cancer cells in vivo. J Surg Res. 151:68–73. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Hama Y, Koyama Y, Urano Y, Choyke PL and
Kobayashi H: Simultaneous two-color spectral fluorescence
lymphangiography with near infrared quantum dots to map two
lymphatic flows from the breast and the upper extremity. Breast
Cancer Res Treat. 103:23–28. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Stacker SA, Achen MG, Jussila L, Baldwin
ME and Alitalo K: Lymphangiogenesis and cancer metastasis. Nat Rev
Cancer. 2:573–583. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
66
|
Nibbs RJ, Kriehuber E, Ponath PD, et al:
The beta-chemokine receptor D6 is expressed by lymphatic
endothelium and a subset of vascular tumors. Am J Pathol.
158:867–877. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Irjala H, Johansson EL, Grenman R, Alanen
K, Salmi M and Jalkanen S: Mannose receptor is a novel ligand for
L-selectin and mediates lymphocyte binding to lymphatic
endothelium. J Exp Med. 194:1033–1042. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Schacht V, Ramirez MI, Hong YK, et al:
T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature
formation and causes lymphedema. EMBO J. 22:3546–3556. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Jackson DG: Biology of the lymphatic
marker LYVE-1 and applications in research into lymphatic
trafficking and lymphangiogenesis. APMIS. 112:526–538. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Hong YK, Harvey N, Noh YH, Schacht V,
Hirakawa S, Detmar M and Oliver G: Prox1 is a master control gene
in the program specifying lymphatic endothelial cell fate. Dev Dyn.
225:351–357. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Marchionni L, Wilson RF, Marinopoulos SS,
Wolff AC, Parmigiani G, Bass EB and Goodman SN: Impact of gene
expression profiling tests on breast cancer outcomes. Evid Rep
Technol Assess (Full Rep). 160:1–105. 2007.PubMed/NCBI
|
|
72
|
Paik S, Shak S, Tang G, et al: A multigene
assay to predict recurrence of tamoxifen-treated, node-negative
breast cancer. N Engl J Med. 351:2817–2826. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Nielsen TO, Parker JS, Leung S, et al: A
comparison of PAM50 intrinsic subtyping with immunohistochemistry
and clinical prognostic factors in tamoxifen-treated estrogen
receptor-positive breast cancer. Clin Cancer Res. 16:5222–5232.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Cuadros M and Llanos A: Validation and
clinical application of MammaPrint® in patients with breast cancer.
Med Clin (Barc). 136:627–632. 2011.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Bartlett JM, Thomas J, Ross DT, et al:
Mammostrat as a tool to stratify breast cancer patients at risk of
recurrence during endocrine therapy. Breast Cancer Res. 12:R472010.
View Article : Google Scholar : PubMed/NCBI
|
